EmeritusDX Announces Launch of New Molecular Test, MetaDX&#x

Irvine, CA (PRWEB) May 24, 2023 -- EmeritusDX, a rapidly growing cancer diagnostics and information company, today announced the commercial availability of

Related Keywords

Robert Embree , , Androgen Deprivation Therapy , Chief Executive Officer ,